Latest news
Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:21:45 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMTMSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMTApplied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:21:00 GMTSummit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer - Business WireBusiness Wire · Wed, 05 Aug 2026 11:00:00 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTPhase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient - News-MedicalNews-Medical · Mon, 27 Jul 2026 07:00:00 GMT